According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current earnings are S$0.11 Billion. In 2024 the company made an earning of S$30.22 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.